The effect of minocycline on motor neuron recovery and neuropathic pain in a rat model of spinal cord injury

Journal of Korean Neurosurgical Society

Volumn 49, Issue 2, 2011, Pages 83-91

  Cho, Dong Charn ^a   Cheong, Jin Hwan ^a   Yang, Moon Sul ^a   Hwang, Se Jin ^a   Kim, Jae Min ^a   Kim, Choong Hyun ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Astrocyte; Microglia; Minocycline; Spinal cord injury

Indexed keywords

CALCIUM BINDING PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1 PROTEIN; MINOCYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL ASSAY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MICROGLIA; MOTONEURON; NEUROPATHIC PAIN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SPINAL CORD DORSAL HORN; SPINAL CORD INJURY; SPINAL CORD VENTRAL HORN; UPREGULATION;

EID: 79955425304     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2011.49.2.83     Document Type: Article

References (38)

1. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, et al.: A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A 93: 14014-14019, 1996
2. Anthes DL, Theriault E, Tator CH: Ultra structural evidence for arteriolar vasospasm after spinal cord trauma. Neurosurgery 39: 804-814, 1996
3. Baptiste DC, Fehlings MG: Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 23: 318-334, 2006
4. Basso DC, Beattie MG, Bresnahan JC: Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139: 244-256, 1996
5. Bracken MB: Treatment of acute spinal cord injury with methylprednisolone: results of a multi center, randomized clinical trial. J Neurotrauma 8 Suppl 1: S47-S50; discussion S51-S52, 1991
6. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, et al.: Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 89: 699-706, 1998
7. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63, 1994
8. Colburn RW, Rickman AJ, DeLeo JA: The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 157: 289-304, 1999
9. De Vivo MJ: Causes and costs of spinal cord injury in the United States. Spinal Cord 35: 809-B13, 1997
10. Festoff BW, Ameenuddin S, Arnold PM, Wong A, Santacruz KS, Citron BA: Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J Neurochem 97: 1314-1326, 2006
11. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR: Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2: 297-321, 1991
12. Hall ED: The neuroprotective pharmacology of methylprednisolone. J Neurosurg 76: 13-22, 1992
13. Hauben E, Gothilf A, Cohen A, Butovsky O, Nevo U, Smirnov I, et al.: Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J Neurosci 23: 8808-8819, 2003
14. Hurlbert RJ: Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 93: 1-7, 2000
15. Jiang F, Liu T, Cheng M, Pang XY, Bai ZT, Zhou JJ, et al.: Spinal astrocyte and microglial activation contributes to rat pain-related behaviors induced by the venom of scorpion buthus martensi karch. Eur J Pharmacol 623: 52-64, 2009
16. Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC, et al.: Pathological cns autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci 22: 2690-2700, 2002
17. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR: Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4: 451-464, 2004
18. Lammertse DP: Update on pharmaceutical trials in acute spinal cord injury. J Spinal Cord Med 27: 319-325, 2004
19. Lee YL, Shih K, Bao P, Ghirnikar RS, Eng LF: Cytokine chemokine expression in contused rat spinal cord. Neurochem Int 36: 417-425, 2000
20. Popovich PG: Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog Brain Res 128: 43-58, 2000
21. Qiu J: China spinal cord injury network: Changes from within. Lancet Neurol 8: 606-607, 2009
22. Rabchevsky AG, Fugaccia I, Sullivan PG, Blades DA, Scheff SW: Efficacy of methylprednisolone therapy for the injured rat spinal cord. J Neurosci Res 68: 7-18, 2002
23. Rideout HJ, Stefanis L: Caspase inhibition: a potential therapeutic strategy in neurological diseases. Histol Histopathol 16: 895-908, 2001
24. Romero-Sandoval A, Chai N, Nutile-McMenemy N, DeLeo JA: A comparison of spinal iba1 and gfap expression in rodent models of acute and chronic pain. Brain Res 1219: 116-126, 2008
25. Rothman SM, Winkelstein BA: Chemical and mechanical nerve root insults induce differential behavioral sensitivity and glial activation that are enhanced in combination. Brain Res 1181: 30-43, 2007
26. Saganová K, Orendácova J, Cízková D, Vanický I: Limited minocycline neuroprotection after balloon-compression spinal cord injury in the rat. Neurosci Lett 433: 246-249, 2008
27. Schwab JM, Brechtel K, Mueller CA, Failli V, Kaps HP, Tuli SK, et al.: Experimental strategies to promote spinal cord regeneration--an integrative perspective. Prog Neurobiol 78: 91-116, 2006
28. Schwab JM, Seid K, Schluesener HJ: Traumatic brain injury induces prolonged accumulation of cyclooxygenase-1 expressing microglia/brain macrophages in rats. J Neurotrauma 18: 881-890, 2001
29. Shin MS, Chung BS, Kim YS: Effect of cyclosporin a in a rat spinal cord injury model. J Korean Neurosurg Soc 27: 1361-1369, 1998
30. Short DT, el Masry WS, Jones PW: High dose methylprednisolone in the management of acute spinal cord injury-a systematic review from a clinical perspective. Spinal Cord 38: 273-286, 2000
31. Smirnova IV, Citron BA, Arnold PM, Festoff BW: Neuroprotective signal transduction in model motor neurons exposed to thrombin: G-protein modulation effects on neurite outgrowth, Ca(2+) mobilization, and apoptosis. J Neurobiol 48: 87-100, 2001
32. Springer JE, Azbill RD, Knapp PE: Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med 5: 943-946, 1999
33. Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, et al.: Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci U S A 101: 3071-3076, 2004
34. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J: Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21: 2580-2588, 2001
35. Tozaki-Saitoh H, Tsuda M, Miyata H, Ueda K, Kohsaka S, Inoue K: P2y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J Neurosci 28: 4949-4956, 2008
36. von Bernhardi R, Ramirez G: Microglia astrocyte interaction in alzheimer's disease: friends or foes for the nervous system? Biol Res 34: 123-128, 2001
37. Wasserman JK, Schlichter LC: Neuron death and inflammation in a rat model of intracerebral hemorrhage: effects of delayed minocycline treatment. Brain Res 1136: 208-218, 2007
38. Yune TY, Lee JY, Jung GY, Kim SJ, Jiang MH, Kim YC, et al.: Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci 27: 7751-7761, 2007